Search
SOLACI Congress
HomePresentations

Presentations

View Category
Presentations

Lotus Valve System for Transcatheter Aortic Valve Implantation/Replacement (TAVI/R) Evidence

Eberhard Grube2014-10-30MD, FACC, FSCAIUniversity Hospital, Dept of Medicine II, Bonn, GermanyStanford University, Palo Alto, California, USA 
solaci -
Learn More
Presentations

Fibrilación Auricular: Tratamiento Medico

Efrain Gil R. 2014-10-30ELECTROFISIOLOGO
solaci -
Learn More
Presentations

Manejo Aneurismas Popliteos

Andres Fajardo 2014-10-30MD FACSCIRUGIA VASCULARINDIANA UNIVERSITY
solaci -
Learn More
Presentations

Endoprotesis Fenestradas

Andres Fajardo 2014-10-30MD FACSCIRUGIA VASCULARINDIANA UNIVERSITY
solaci -
Learn More
Presentations

Manejo de las lesiones de TASC A a TASC D

Fernando Cura2014-10-30Jefe de Cardiología Intervencionista y Terapéuticas EndovascularesICBA - Argentina
solaci -
Learn More
Presentations

Two Clip or Not Two Clip

Saibal Kar2014-10-30MD, FACC, FAHA, FSCAIHeart Institute, Cedars Sinai Medical CenterLos Angeles, CA
solaci -
Learn More
Presentations

Endovascular treatment of Mitral Paravalvular Leaks

Saibal Kar2014-10-30MD, FACC, FAHA, FSCAIHeart Institute, Cedars Sinai Medical Center, Los Angeles, CA
solaci -
Learn More
Presentations

CoreValve for High Risk and Extreme Risk Patients; The US Pivotal Trials

Eduardo de Marchena2014-10-30M.D., F.A.C.C., F.A.C.P., F.S.C.A.I.Professor of Medicine & SurgeryAssociate Dean for International MedicineDirector of Interventional CardiologyUniversity...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Evolution of Small Balloon-Expandable Valves

Dr. Carlos Fava - 0
Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

solaci - 0
Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

Dr. Carlos Fava - 0
The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

Institutional News

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Arequipa Sessions 2024: Meet the International Guests

solaci - 0
The Arequipa Sessions 2024 is getting closer and closer. Meet the international guests who will share their knowledge for 2 days at a high-level...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy